# Proacta

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/proacta

- Industry: Pharmaceuticals
- Headquarters: US
- Website: www.proacta.com
- Total disclosed funding: $43M
- Latest round: Series B (Feb 7, 2007)
- Investors on record: 9

## About

Proacta, Inc. specializes in offering comprehensive online branding solutions, facilitating a robust domain marketplace, and providing innovative tools for business identity establishment.Proacta, Inc. was founded in 2004 by Bill Wilson in the United States. The company operates primarily through its platform, Atom.com, offering domain-related services. Proacta has successfully closed 9 deals and has raised a total of USD 0.49 mn in funding, with the latest round being USD 0.49 mn. Bill Wilson has a history of founding other ventures, contributing to Proacta's strategic direction.Proacta specializes in providing a comprehensive suite of domain-related services through its platform, Atom.com. Their offerings include over 300,000 expert-curated domain names with modern extensions like .ai, .io, and .xyz, along with naming contests, AI-powered name generators, logo design services, and trademark protection to enhance branding for startups and established companies alike. Their customer base includes entrepreneurs, small to medium-sized enterprises, and larger brands across North America, Europe, and Asia.Proacta generates revenue mainly through the sale of domain names and associated services on the Atom.com marketplace. Customers purchase domain names directly and utilize AI-powered tools for name generation, often engaging in naming contests that involve additional expert service fees. The pricing structure varies based on domain complexity and exclusivity, complemented by potential costs for logo design and trademark services, emphasizing a B2B focus for reliable branding solutions.Proacta plans to leverage recent funding to enhance its product offerings and expand into new geographic regions. Upcoming product launches include advanced branding tools and enhanced AI features for domain services, with anticipated releases within the next year. The company is targeting expansion into emerging markets in Asia by the end of the next fiscal year. The recent funding will support these initiatives, assisting in the development of innovative tools and the enhancement of their global outreach.

## Funding rounds

- Series B, Feb 7, 2007, $35M — Alta Partners, Delphi Ventures, GBS Venture Partners, No 8 Ventures, New Zealand Growth Capital Partners, Clarus Ventures, Genentech, Inc., Roche Venture Fund
- Series A, Jun 24, 2004, $8M — GBS Venture Partners, I-CAP Partners, No 8 Ventures, Genentech, Inc., Roche Venture Fund

## Investors

- GBS Venture Partners (https://capitalatlas.ai/funds/gbs-venture-partners) — Series A, Series B
- I-CAP Partners (https://capitalatlas.ai/funds/i-cap-partners) — Series A
- No 8 Ventures (https://capitalatlas.ai/funds/no-8-ventures) — Series A, Series B
- Genentech, Inc. — Series A, Series B
- Roche Venture Fund (https://capitalatlas.ai/funds/roche-venture-fund) — Series A, Series B
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series B
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series B
- New Zealand Growth Capital Partners — Series B
- Clarus Ventures (https://capitalatlas.ai/funds/clarus-ventures) — Series B